REGIS HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4 AUD | +0.76% |
|
+2.56% | +23.08% |
| Mar. 18 | Regis Healthcare Limited(ASX:REG) added to S&P/ASX Small Ordinaries Index | CI |
| Mar. 18 | Regis Healthcare Limited(ASX:REG) added to S&P/ASX 300 Index | CI |
Valuation
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 790.7 | 424.1 | 586.5 | 556.5 | 668 | 1,195 | - | - |
| Enterprise Value (EV) 1 | 1,094 | 660.7 | 729 | 665.8 | 677.8 | 1,232 | 1,200 | 1,179 |
| P/E ratio | 15.6 x | 113 x | 29.4 x | -14.3 x | -23.5 x | -60.8 x | 27.9 x | 26.3 x |
| Yield | 5.79% | 2.85% | 3.4% | 3.16% | 4.27% | 2.84% | 2.94% | 3.37% |
| Capitalization / Revenue | 1.22 x | 0.63 x | 0.75 x | 0.7 x | 0.74 x | 1.17 x | 1.08 x | 1.03 x |
| EV / Revenue | 1.69 x | 0.97 x | 0.93 x | 0.84 x | 0.76 x | 1.21 x | 1.08 x | 1.02 x |
| EV / EBITDA | 9.37 x | 4.59 x | 4.96 x | 4.69 x | 8.14 x | 11.6 x | 9.91 x | 9.09 x |
| EV / FCF | 7.05 x | 7.51 x | 8.44 x | 10.1 x | 13.1 x | 42.7 x | 10 x | 8.8 x |
| FCF Yield | 14.2% | 13.3% | 11.9% | 9.93% | 7.63% | 2.34% | 9.96% | 11.4% |
| Price to Book | 4.43 x | 2.88 x | 4.13 x | 7.04 x | 17.4 x | -16.2 x | -21.2 x | -29 x |
| Nbr of stocks (in thousands) | 300,654 | 300,748 | 300,781 | 300,834 | 300,908 | 301,035 | - | - |
| Reference price 2 | 2.630 | 1.410 | 1.950 | 1.850 | 2.220 | 3.970 | 3.970 | 3.970 |
| Announcement Date | 8/21/19 | 8/26/20 | 8/30/21 | 8/23/22 | 8/24/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 647.1 | 677.9 | 784.4 | 797 | 897.6 | 1,022 | 1,108 | 1,158 |
| EBITDA 1 | 116.7 | 143.9 | 147 | 142 | 83.3 | 106.4 | 121 | 129.7 |
| EBIT 1 | 77.5 | 99.9 | 93.95 | 85.56 | 38.22 | 57.09 | 69.29 | 75.87 |
| Operating Margin | 11.98% | 14.74% | 11.98% | 10.74% | 4.26% | 5.58% | 6.25% | 6.55% |
| Earnings before Tax (EBT) 1 | 69.6 | 12.1 | 29.15 | -55.18 | -40.38 | 49.01 | 59.87 | 63.8 |
| Net income 1 | 50.9 | 3.764 | 19.95 | -38.8 | -28.45 | -20.47 | 42.83 | 44.92 |
| Net margin | 7.87% | 0.56% | 2.54% | -4.87% | -3.17% | -2% | 3.86% | 3.88% |
| EPS 2 | 0.1691 | 0.0125 | 0.0663 | -0.1290 | -0.0946 | -0.0653 | 0.1424 | 0.1510 |
| Free Cash Flow 1 | 155.2 | 87.94 | 86.39 | 66.14 | 51.68 | 28.83 | 119.5 | 134 |
| FCF margin | 23.99% | 12.97% | 11.01% | 8.3% | 5.76% | 2.82% | 10.78% | 11.57% |
| FCF Conversion (EBITDA) | 133.02% | 61.11% | 58.77% | 46.58% | 62.04% | 27.1% | 98.73% | 103.35% |
| FCF Conversion (Net income) | 305% | 2,336.42% | 433.07% | - | - | - | 279.03% | 298.29% |
| Dividend per Share 2 | 0.1523 | 0.0402 | 0.0663 | 0.0584 | 0.0948 | 0.1129 | 0.1166 | 0.1338 |
| Announcement Date | 8/21/19 | 8/26/20 | 8/30/21 | 8/23/22 | 8/24/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 361.5 | - | 379.2 | 405.2 | 395.6 | - | 413.7 | 483.9 | 524.3 | - | - |
| EBITDA 1 | 74.3 | 69.6 | 76.67 | 80 | 44.11 | - | 45.1 | 38.2 | 54.25 | - | - |
| EBIT 1 | 54.2 | 45.7 | 54.24 | 39.71 | 35.01 | - | 22.44 | 15.78 | 26.25 | - | - |
| Operating Margin | 14.99% | - | 14.3% | 9.8% | 8.85% | - | 5.42% | 3.26% | 5.01% | - | - |
| Earnings before Tax (EBT) | - | -5.2 | 15.86 | 13.29 | -5.132 | - | - | - | - | - | - |
| Net income 1 | 12.1 | -8.3 | 11 | 8.946 | -3.669 | - | -25.91 | -2.542 | -2.7 | - | - |
| Net margin | 3.35% | - | 2.9% | 2.21% | -0.93% | - | -6.26% | -0.53% | -0.51% | - | - |
| EPS | 0.0402 | -0.0277 | 0.0366 | 0.0297 | -0.0122 | -0.1168 | -0.0861 | - | - | 0.0700 | 0.0800 |
| Dividend per Share 2 | 0.0402 | - | 0.0200 | 0.0463 | 0.0352 | - | 0.0200 | 0.0748 | 0.0515 | - | - |
| Announcement Date | 2/25/20 | 8/26/20 | 2/23/21 | 8/30/21 | 2/22/22 | 8/23/22 | 2/26/23 | 8/24/23 | - | - | - |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 303 | 237 | 142 | 109 | 9.75 | 37.4 | 4.45 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | 16 |
| Leverage (Debt/EBITDA) | 2.598 x | 1.645 x | 0.9691 x | 0.7698 x | 0.117 x | 0.3515 x | 0.0368 x | - |
| Free Cash Flow 1 | 155 | 87.9 | 86.4 | 66.1 | 51.7 | 28.8 | 120 | 134 |
| ROE (net income / shareholders' equity) | 28.4% | 13.2% | 14.8% | -35.1% | -48.5% | 358% | 79.3% | 287% |
| ROA (Net income/ Total Assets) | 2.87% | 1.2% | 1.12% | -2.24% | -1.68% | 2.64% | 3.06% | 3.18% |
| Assets 1 | 1,776 | 314.1 | 1,776 | 1,735 | 1,692 | -774.2 | 1,400 | 1,413 |
| Book Value Per Share 2 | 0.5900 | 0.4900 | 0.4700 | 0.2600 | 0.1300 | -0.2500 | -0.1900 | -0.1400 |
| Cash Flow per Share 2 | 0.7300 | 0.4200 | 0.3500 | 0.2200 | 0.3000 | 0.4300 | 0.3700 | 0.4000 |
| Capex 1 | 64.9 | 39.3 | 18.6 | 48.6 | 53.5 | 58.8 | 78.6 | 94.5 |
| Capex / Sales | 10.03% | 5.8% | 2.38% | 6.1% | 5.96% | 5.75% | 7.09% | 8.16% |
| Announcement Date | 8/21/19 | 8/26/20 | 8/30/21 | 8/23/22 | 8/24/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
3.97
AUD
Average target price
3.998
AUD
Spread / Average Target
+0.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.08% | 779M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +4.61% | 10.79B | |
| -0.21% | 7.68B | |
| +18.43% | 7.06B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B | |
| -5.12% | 4.25B |
- Stock Market
- Equities
- REG Stock
- Financials Regis Healthcare Limited
